BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1355332)

  • 1. Atrial natriuretic peptide-induced inhibition of aldosterone secretion: a quest for mediator(s).
    Ganguly A
    Am J Physiol; 1992 Aug; 263(2 Pt 1):E181-94. PubMed ID: 1355332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion.
    Barrett PQ; Isales CM
    Endocrinology; 1988 Mar; 122(3):799-808. PubMed ID: 2830096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of atrial natriuretic peptide on ACTH, dibutyryl cAMP, angiotensin II and potassium-stimulated aldosterone secretion by rat adrenal glomerulosa cells.
    Schiebinger RJ; Kem DC; Brown RD
    Life Sci; 1988; 42(8):919-26. PubMed ID: 2830448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide inhibition of calcium ionophore A23187-stimulated aldosterone secretion in rat adrenal glomerulosa cells.
    Lotshaw DP; Franco-Saenz R; Mulrow PJ
    Endocrinology; 1991 Nov; 129(5):2305-10. PubMed ID: 1657569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide inhibits the stimulation of aldosterone secretion by ACTH in vitro and in vivo.
    Chartier L; Schiffrin EL
    Proc Soc Exp Biol Med; 1986 May; 182(1):132-6. PubMed ID: 3008159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of calcium in effects of atrial natriuretic peptide on aldosterone production in adrenal glomerulosa cells.
    Chartier L; Schiffrin EL
    Am J Physiol; 1987 Apr; 252(4 Pt 1):E485-91. PubMed ID: 2436485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of ANP-binding sites in the adrenal capsules of term-pregnant rats.
    Forcier I; St-Louis J; Brochu M
    Mol Cell Endocrinol; 1996 Mar; 117(2):189-94. PubMed ID: 8737379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide inhibits the stimulation of aldosterone secretion but not the transient increase in intracellular free calcium concentration induced by angiotensin II addition.
    Apfeldorf WJ; Isales CM; Barrett PQ
    Endocrinology; 1988 Apr; 122(4):1460-5. PubMed ID: 2964364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide inhibits calcium-induced steroidogenic acute regulatory protein gene transcription in adrenal glomerulosa cells.
    Cherradi N; Brandenburger Y; Rossier MF; Vallotton MB; Stocco DM; Capponi AM
    Mol Endocrinol; 1998 Jul; 12(7):962-72. PubMed ID: 9658401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of physiological levels of atrial natriuretic peptide on hormone secretion: inhibition of angiotensin-induced aldosterone secretion and renin release in normal man.
    Cuneo RC; Espiner EA; Nicholls MG; Yandle TG; Livesey JH
    J Clin Endocrinol Metab; 1987 Oct; 65(4):765-72. PubMed ID: 2821056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide (ANP) antagonist of microbial origin. II. Restoration by HS-142-1 of ANP-induced inhibition of aldosterone production in adrenal glomerulosa cells.
    Oda S; Sano T; Morishita Y; Matsuda Y
    J Pharmacol Exp Ther; 1992 Oct; 263(1):241-5. PubMed ID: 1328608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of aldosterone secretion.
    Mulrow PJ; Takagi M; Takagi M; Franco-Saenz R
    J Steroid Biochem; 1987; 27(4-6):941-6. PubMed ID: 2826913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ANP on sustained aldosterone secretion stimulated by angiotensin II.
    Isales CM; Bollag WB; Kiernan LC; Barrett PQ
    Am J Physiol; 1989 Jan; 256(1 Pt 1):C89-95. PubMed ID: 2521426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic factor receptor heterogeneity and stimulation of particulate guanylate cyclase and cyclic GMP accumulation.
    Leitman DC; Murad F
    Endocrinol Metab Clin North Am; 1987 Mar; 16(1):79-105. PubMed ID: 2892671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human alpha atrial natriuretic peptide inhibits angiotensin stimulated aldosterone biosynthesis in bovine adrenal glands.
    Frisina N; Buemi M; Lasco A; Macri I; Squadrito F
    Horm Metab Res; 1987 Jul; 19(7):309-11. PubMed ID: 2957298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo.
    Chartier L; Schiffrin E; Thibault G; Garcia R
    Endocrinology; 1984 Nov; 115(5):2026-8. PubMed ID: 6092045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic polypeptide inhibits cortisol secretion as well as aldosterone secretion in vitro from human adrenal tissue.
    Naruse M; Obana K; Naruse K; Yamaguchi H; Demura H; Inagami T; Shizume K
    J Clin Endocrinol Metab; 1987 Jan; 64(1):10-6. PubMed ID: 3023424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natriuretic peptides receptors in human aldosterone-secreting adenomas.
    Sarzani R; Opocher G; Paci MV; Belloni AS; Mantero F; Dessì-Fulgheri P; Rappelli A
    J Endocrinol Invest; 1999; 22(7):514-8. PubMed ID: 10475148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of endogenous ouabain by atrial natriuretic peptide is a guanylyl cyclase independent effect.
    Tegin G; Gao Y; Hamlyn JM; Clark BJ; El-Mallakh RS
    PLoS One; 2021; 16(11):e0260131. PubMed ID: 34793577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.